Q32 Bio

Biotechnology Research • Waltham, Massachusetts, United States • 21-50 Employees

Company overview

Headquarters	830 Winter St, 2nd Floor, Waltham, Massachusetts 02451, US
Website	q32bio.com
NAICS	541714
Keywords	Research, Clinical Development, Drug Development, Autoimmune, Alopecia Areata, Inflammatory
Founded	2017
Employees	21-50
Socials

Key Contacts at Q32 Bio

Kristin Orr

Senior Director Clinical Operations

Abigail Watanabe

Director Of Business Operations & Facilities

Claire Galand

Director Translational Biology

Katie Burke

Senior Director, Finance And Sec Reporting

Jill Danis

Associate Director, Accounting

Kelly Leboeuf Fahnoe

Senior Director, Research Management & Protein Science

Fei Liu

Director, Pharmacology

Cheri Mullaney

Director Of Financial Planning And Analysis

Q32 Bio Email Formats

Q32 Bio uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@q32bio.com), used 90% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@q32bio.com	90%
{first initial}{last name}	jdoe@q32bio.com	10%

About Q32 Bio

Q32 Bio is a clinical stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity and is focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases. Per the National Alopecia Areata Foundation, about 700,000 people in the United States live with alopecia areata, a disease which has a life-altering impact on patients and limited current treatment options. The Company is advancing bempikibart (ADX-914), a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function, for the treatment of alopecia areata in an ongoing Phase 2 program. The IL-7 and TSLP pathways have been genetically and biologically implicated in driving several T cell-mediated pathological processes in numerous autoimmune diseases.

Q32 Bio revenue & valuation

Annual revenue	$2,652,205
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,500,000
Total funding	$144,000,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Manager

Entry

Employees by Department

Q32 Bio has 13 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Q32 Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2020-11-29	5	$60,000,000
2024-04-25	1	$42,000,000
2024-04-25	14	$42,000,000

Funding Insights

$144,000,000

Total funding amount

$42,000,000

Most recent funding amount

Number of funding rounds

Q32 Bio Tech Stack

Discover the technologies and tools that power Q32 Bio's digital infrastructure, from frameworks to analytics platforms.

Draftpress HFCM

WordPress plugins

Twitter Emoji

Font scripts

UserWay

Accessibility

Google Tag Manager

Tag managers

GoDaddy

Hosting

Nginx

Reverse proxies

Contact Form 7

Form builders

PHP

Programming languages

Open Graph

Miscellaneous

Vimeo

Video players

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

Q32 Bio is located in Waltham, Massachusetts, US.

Q32 Bio was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Q32 Bio has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Q32 Bio has raised a total of $144,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.